Delivery Order SPE2DB22D2009-SPE2DB25FM0VG
Award Date 8/12/25
Potential Completion Date 8/13/25
Potential Value $134K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $140,147 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. The order will be fulfilled at the company's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. This is a competitively awarded contract with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal vaccine...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,330.50 with an ultimate completion date of August 21, 2025. The contract is not set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Boostrix TDAP vaccine in 0.5ml syringes. This competitively awarded, non-set-aside contract carries a ceiling value of $9,404.28 under a firm fixed-price arrangement, with performance to be completed by September 2, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical and healthcare...
- The Defense Logistics Agency awarded a $4,733.48 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This non-set-aside contract, which carries an ultimate completion date of August 14, 2025, operates under a firm fixed price structure. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this order. The contract represents a small-value transaction typical of routine...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes, with a ceiling value of $14,722.52. This is a firm fixed-price delivery order with an ultimate completion date of June 20, 2025, and represents a non-competitive set-aside procurement. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes, valued at $18,399.97 with a firm fixed price structure. This competitively awarded, non-set-aside delivery order is scheduled for completion by August 19, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small component of the...
- The Defense Logistics Agency awarded a delivery order valued at $97,516.35 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5mL syringes on August 19, 2025, with completion scheduled for August 20, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $52,873.75 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This firm fixed-price, competitively awarded delivery order has an ultimate completion date of July 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier...
- The Defense Logistics Agency awarded a $23,708.20 delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5mL) under a firm fixed-price contract type. The award was made on September 9, 2025, with an ultimate completion date of September 10, 2025, and represents a non-set-aside competitive award. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary pharmaceutical distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $3,696.56, for Boostrix TDAP vaccine in 0.5mL syringe format. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of July 18, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. Performance...